AI-generated summary
The authors report a split-face randomized trial of 27 patients with atrophic acne scars treated with a 1927-nm fractional thulium fiber laser, with one side receiving a topical recombinant GM-CSF gel for 7 days and the other side no intervention. They report faster scab resolution and less erythema with the gel, and a greater reduction in melanin index at one and two months. Scar improvement was similar on both sides.
- Participants
- 27
- Who or what was studied
- Adults with atrophic acne scars (27 patients completed the study of 30 enrolled)
- Wavelengths
- 1927 nm
- Limits stated in the abstract
- The abstract does not describe the sample size calculation or the specific measures behind the reported differences, and the study is a single trial with limited follow-up of 60 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wound healing, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.